# Case report: An atypical case of uterine adenosarcoma with extensive bizarre stromal cells and amplification of MDM2

**Authors:** Xiaoling Xiao, Ying He

PMC · DOI: 10.3389/fonc.2024.1351646 · Frontiers in Oncology · 2024-03-14

## TL;DR

This case report describes an unusual uterine adenosarcoma with unique features and MDM2 amplification.

## Contribution

The paper presents a novel atypical adenosarcoma case with extensive bizarre stromal cells and MDM2 amplification.

## Key findings

- The tumor lacked typical histological features of adenosarcoma but showed benign epithelium and hyperplastic stroma.
- Stromal cells were positive for vimentin, CD10, ER, PR, cyclin D1, and P16 but negative for caldesmon.
- MDM2 amplification was confirmed using FISH and NGS.

## Abstract

Polypoid lesions in the uterus are very common. There are a lot of benign lesions and malignant tumor should be considered. Adenosarcoma, one of the differential diagnoses, is a rare mixed epithelial and mesenchymal tumor consisting of benign epithelial components and sarcoma stroma. Here, we present a case of atypical adenosarcoma that has never been reported. This tumor was composed of benign endometrial epithelium and hyperplastic stroma with extensive bizarre stromal cells. But the cleft-like spaces and papillary stomal fronds which were the typical histological images of adenosarcoma were absent. These stomal cells, including bizarre cells, were positive for vimentin, CD10, ER, PR, cyclin D1 and P16 but were immunonegative for caldesmon. Furthermore, this tumor harbored amplification of MDM2, as revealed by fluorescence in situ hybridization testing (FISH) and next-generation DNA sequencing (NGS).

## Linked entities

- **Genes:** MDM2 (MDM2 proto-oncogene) [NCBI Gene 4193]
- **Proteins:** PRELID1 (PRELI domain containing 1), MME (membrane metalloendopeptidase), EREG (epiregulin), PGR (progesterone receptor), ccnd1.S (cyclin D1 S homeolog), CDKN2A (cyclin dependent kinase inhibitor 2A), Cald1 (caldesmon 1)
- **Diseases:** adenosarcoma (MONDO:0005636), uterine adenosarcoma (MONDO:0002878)

## Full-text entities

- **Genes:** MDM2 (MDM2 proto-oncogene) [NCBI Gene 4193] {aka ACTFS, HDMX, LSKB, hdm2}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, VIM (vimentin) [NCBI Gene 7431], CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, CALD1 (caldesmon 1) [NCBI Gene 800] {aka CDM, H-CAD, HCAD, L-CAD, LCAD, NAG22}
- **Diseases:** Polypoid lesions in the (MESH:D000092342), sarcoma (MESH:D012509), epithelial and mesenchymal tumor (MESH:D002277), uterine adenosarcoma (MESH:C538232), malignant (MESH:D009369), Adenosarcoma (MESH:D018195)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10972885/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10972885/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC10972885/full.md

---
Source: https://tomesphere.com/paper/PMC10972885